中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (3): 204-210.doi: 10.3969/j.issn.1000-6621.2021.03.003
收稿日期:
2021-01-20
出版日期:
2021-03-10
发布日期:
2021-03-03
通信作者:
高磊
E-mail:gaolei@ipbcams.ac.cn
基金资助:
HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei()
Received:
2021-01-20
Online:
2021-03-10
Published:
2021-03-03
Contact:
GAO Lei
E-mail:gaolei@ipbcams.ac.cn
摘要:
中国是结核病和结核分枝杆菌感染高负担国家,针对感染和发病的高危人群开展预防干预是结核病防控工作的重要内容。结核菌素皮肤试验作为一种成熟的结核分枝杆菌感染的免疫学检测方法,尽管其结果受卡介苗接种、环境非结核分枝杆菌感染、宿主免疫状态等多种因素的影响,但在高危人群筛查、结核病辅助诊断、重点人群监测等工作中发挥着重要作用。结合中国国情及结核分枝杆菌感染的流行特征,通过优化应用策略可以在有效控制影响因素的基础上发挥结核菌素皮肤试验作为感染筛查手段的优势;同时,在科学数据支撑下,针对不同目标人群细化应用和结果解读也将为其更好地服务中国结核病防控工作提供质量保证。
何翼君, 张浩然, 辛赫男, 高磊. 结核菌素皮肤试验的应用及其优化[J]. 中国防痨杂志, 2021, 43(3): 204-210. doi: 10.3969/j.issn.1000-6621.2021.03.003
HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei. Optimizing the application of tuberculin skin test[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 204-210. doi: 10.3969/j.issn.1000-6621.2021.03.003
[1] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[2] |
Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016,13(10):e1002152. doi: 10.1371/journal.pmed.1002152.
doi: 10.1371/journal.pmed.1002152 URL pmid: 27780211 |
[3] |
O’Garra A, Redford PS, McNab FW, et al. The immune response in tuberculosis. Annu Rev Immunol, 2013,31:475-527. doi: 10.1146/annurev-immunol-032712-095939.
doi: 10.1146/annurev-immunol-032712-095939 URL pmid: 23516984 |
[4] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[5] |
Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis, 1993,17(6):968-975. doi: 10.1093/clinids/17.6.968.
doi: 10.1093/clinids/17.6.968 URL pmid: 8110954 |
[6] |
Turk JL. Von Pirquet, allergy and infectious diseases: a review. J R Soc Med, 1987,80(1):31-33.
URL pmid: 3550077 |
[7] | Von Pirquet C. Frequency of tuberculosis in childhood. JAMA, 1909,LII(9):675-678. doi: 10.1001/jama.1909.25420350001001. |
[8] | Edwards PQ, Edwads LB. Story of the tuberculin test from an epidemiologic viewpoint. Am Rev Respir Dis, 1960, 81(1)Pt 2:1-47. |
[9] |
Affronti LF, Caprio JJ, Edwards PQ, et al. What is PPD-S? A statement by the Committee on Diagnostic Skin Testing. Am Rev Respir Dis, 1969,99(3):460-461. doi: 10.1164/arrd.1969.99.3.460.
doi: 10.1164/arrd.1969.99.3.460 URL pmid: 5765640 |
[10] |
Yang H, Kruh-Garcia NA, Dobos KM. Purified protein deriva-tives of tuberculin--past, present, and future. FEMS Immunol Med Microbiol, 2012,66(3):273-280. doi: 10.1111/j.1574-695X.2012.01002.x.
doi: 10.1111/j.1574-695X.2012.01002.x URL pmid: 22762692 |
[11] | 都伟欣, 赵爱华, 王国治, 等. 结核菌素类产品的发展历程概述. 中国防痨杂志, 2019,41(10):1080-1083. doi: 10.3969/j.issn.1000-6621.2019.10.003. |
[12] | 全国结核病流行病学抽样调查技术指导组, 全国结核病流行病学抽样调查办公室. 2000年全国结核病流行病学抽样调查报告. 中国防痨杂志, 2002,24(2):3-46. |
[13] |
Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015,15(3):310-319. doi: 10.1016/S1473-3099(14)71085-0.
doi: 10.1016/S1473-3099(14)71085-0 URL pmid: 25681063 |
[14] |
Laurenti P, Raponi M, de Waure C, et al. Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. BMC Infect Dis, 2016,16:131. doi: 10.1186/s12879-016-1461-y.
doi: 10.1186/s12879-016-1461-y URL pmid: 26993789 |
[15] | 中华人民共和国国家卫生计生委办公厅, 中华人民共和国教育部办公厅. 学校结核病防控工作规范(2017版). 国卫办疾控发〔2017〕22号. 2017-06-26. |
[16] | 中华人民共和国国家卫生健康委办公厅, 中华人民共和国教育部办公厅. 中国学校结核病防控指南(2020版). 国卫办疾控函〔2020〕910号. 2020-10-16. |
[17] |
Hartman-Adams H, Clark K, Juckett G. Update on latent tuberculosis infection. Am Fam Physician, 2014,89(11):889-896.
URL pmid: 25077395 |
[18] | Health Protection Surveillance Centre (HPSC), National TB Advisory Committee. Guidelines on the prevention and control of tuberculosis in Ireland 2010. Dublin: Health Protection Surveillance Centre (HPSC), 2010. |
[19] |
American Thoracic Society, American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep, 2000,49(RR-6):1-51.
URL pmid: 10881762 |
[20] |
Adams S, Ehrlich R, Baatjies R, et al. Incidence of occupational latent tuberculosis infection in South African healthcare workers. Eur Respir J, 2015,45(5):1364-1373. doi: 10.1183/09031936.00138414.
doi: 10.1183/09031936.00138414 URL pmid: 25700382 |
[21] |
Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics, 1995,96(1 Pt 1):29-35.
URL pmid: 7596718 |
[22] |
Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis, 2006,10(11):1192-1204.
URL pmid: 17131776 |
[23] |
Gao L, Jin Q. Differences in BCG vaccination and tuberculin skin-test positivity—Authors’ reply. Lancet Infect Dis, 2015,15(9):1003-1005. doi: 10.1016/S1473-3099(15)00251-0.
URL pmid: 26333326 |
[24] |
Yu X, Liu P, Liu G, et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis. J Infect, 2016,73(6):558-567. doi: 10.1016/j.jinf.2016.08.020.
doi: 10.1016/j.jinf.2016.08.020 URL pmid: 27717784 |
[25] |
Jung JY, Lim JE, Lee HJ, et al. Questionable role of inter-feron-γ assays for smear-negative pulmonary TB in immunocompromised patients. J Infect, 2012,64(2):188-196. doi: 10.1016/j.jinf.2011.09.008.
doi: 10.1016/j.jinf.2011.09.008 URL pmid: 22120597 |
[26] | Sollai S, Galli L, de Martino M, et al. Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis, 2014,14 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2334-14-S1-S6. |
[27] |
Nasiri MJ, Pormohammad A, Goudarzi H, et al. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection, 2019,47(3):353-361. doi: 10.1007/s15010-019-01285-7.
URL pmid: 30805899 |
[28] |
Ferguson TW, Tangri N, Macdonald K, et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation, 2015,99(5):1084-1091. doi: 10.1097/TP.0000000000000451.
doi: 10.1097/TP.0000000000000451 URL pmid: 25286055 |
[29] | World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention. Geneva: World Health Organization, 2020. |
[30] |
Magnus K, Edwards LB. The effect of repeated tuberculin testing on post-vaccination allergy; a preliminary note. Lancet, 1955,269(6891):643-644. doi: 10.1016/s0140-6736(55)92482-x.
doi: 10.1016/s0140-6736(55)92482-x URL pmid: 13252947 |
[31] |
Salles CG, Ruffino-Netto A, Lapa-e-Silva JR, et al. The pre-sence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohort. BMC Public Health, 2007,7:38. doi: 10.1186/1471-2458-7-38.
doi: 10.1186/1471-2458-7-38 URL pmid: 17371600 |
[32] | 中华人民共和国国家卫生健康委办公厅. 中国结核病预防控制工作技术规范(2020年版). 国卫办疾控函〔2020〕279号. 2020-04-02. |
[33] | 高磊, 权竹声, 成君, 等. 结核分枝杆菌感染检测两步法在学校结核病控制工作中的应用探讨. 中华预防医学杂志, 2020,54(4):385-391. doi: 10.3760/cma.j.cn112150-20191204-00909. |
[34] | Internal Clinical Guidelines Team (UK). Tuberculosis: Prevention, Diagnosis, Management and Service Organisation. London: National Institute for Health and Care Excellence (UK), 2016. |
[35] |
Schaberg T, Bauer T, Brinkmann F, et al. Tuberculosis Guideline for Adults-Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP). Pneumologie, 2017,71(6):325-397. doi: 10.1055/s-0043-105954.
doi: 10.1055/s-0043-105954 URL pmid: 28651293 |
[36] |
Al Jahdali HH, Baharoon S, Abba AA, et al. Saudi guidelines for testing and treatment of latent tuberculosis infection. Ann Saudi Med, 2010,30(1):38-49. doi: 10.4103/0256-4947.59373.
doi: 10.4103/0256-4947.59373 URL pmid: 20103957 |
[37] |
Erkens CG, Dinmohamed AG, Kamphorst M, et al. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands. Int J Tuberc Lung Dis, 2014,18(4):413-420. doi: 10.5588/ijtld.13.0589.
doi: 10.5588/ijtld.13.0589 URL pmid: 24670695 |
[38] |
Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest, 2007,131(5):1424-1434. doi: 10.1378/chest.06-2728.
doi: 10.1378/chest.06-2728 URL pmid: 17494792 |
[39] |
Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med, 2010,10:7. doi: 10.1186/1471-2466-10-7.
doi: 10.1186/1471-2466-10-7 URL pmid: 20170555 |
[40] |
Muñoz L, Santin M, Alcaide F, et al. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial. Clin Infect Dis, 2018,66(3):396-403. doi: 10.1093/cid/cix745.
doi: 10.1093/cid/cix745 URL pmid: 29020191 |
[41] |
Keshavarz Valian S, Mahmoudi S, Pourakbari B, et al. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test? Arch Environ Occup Health, 2019,74(3):109-114. doi: 10.1080/19338244.2017.1394254.
doi: 10.1080/19338244.2017.1394254 URL pmid: 30516445 |
[42] |
Freund R, Granger B, Francois C, et al. Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy. Presse Med, 2018,47(2):e9-e13. doi: 10.1016/j.lpm.2017.09.029.
doi: 10.1016/j.lpm.2017.09.029 URL pmid: 29478790 |
[43] |
Li H, Xin H, Qian S, et al. Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study. Front Med, 2017,11(4):528-535. doi: 10.1007/s11684-017-0573-0.
URL pmid: 29101754 |
[44] |
Gao L, Li X, Liu J, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2017,17(10):1053-1061. doi: 10.1016/S1473-3099(17)30402-4.
doi: 10.1016/S1473-3099(17)30402-4 URL pmid: 28716677 |
[45] |
Ruhwald M, Aggerbeck H, Gallardo RV, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med, 2017,5(4):259-268. doi: 10.1016/S2213-2600(16)30436-2.
doi: 10.1016/S2213-2600(16)30436-2 URL pmid: 28159608 |
[46] | 中国防痨协会, 中国防痨协会学校与儿童结核病防治专业分会, 《中国防痨杂志》编辑委员会. 重组结核杆菌融合蛋白(EC)临床应用专家共识. 中国防痨杂志, 2020,42(8):761-768. doi: 10.3969/i.issn.1000-6621.2020.08.001. |
[47] |
Cui X, Gao L, Cao B. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries. Int J Infect Dis, 2020,92S:S37-S40. doi: 10.1016/j.ijid.2020.02.034.
doi: 10.1016/j.ijid.2020.02.034 URL pmid: 32114201 |
[1] | 李婷, 何金戈, 苏茜, 李京, 李运葵, 高文凤, 高媛, 杨文. 结核菌素试验在四川省布拖县HIV感染/AIDS患者中筛查结核感染的价值[J]. 中国防痨杂志, 2020, 42(9): 931-936. |
[2] | 李春, 郑海伦, 罗萍, 李亚敏, 赵淑娟, 郭金红, 张丽, 徐静, 屠霞. 2010—2019年北京市大兴区某中学高中部青海藏族集体来京学生肺结核疫情处置分析[J]. 中国防痨杂志, 2020, 42(12): 1318-1322. |
[3] | 房宏霞,章光荣,秦玉宝,解志民,赖铿,黄成章,王艳,何文龙,郑开巧,肖之凯,刘昌伟,梁健平,陈智聪. 封闭社区结核病患者接触者结核感染状况预测模型[J]. 中国防痨杂志, 2019, 41(9): 936-945. |
[4] | 房宏霞,解志民,秦玉宝,罗志理,赖铿,余秀齐,王艳,郑开巧,刘昌伟,陈智聪. 监测封闭社区结核病患者接触者结核感染状况二年的结果分析[J]. 中国防痨杂志, 2019, 41(8): 887-891. |
[5] | 都伟欣,赵爱华,王国治,卢锦标. 结核菌素类产品的发展历程概述[J]. 中国防痨杂志, 2019, 41(10): 1080-1083. |
[6] | 何秀云 黄香玉 朱传智 陈红兵 张翠英 肖漓 高钰 孔祥瑞. PstS1-ESAT-6抗原血清学和γ-干扰素释放试验辅助诊断结核病的价值[J]. 中国防痨杂志, 2016, 38(10): 805-812. |
[7] | 王永红. 对《2008-2014年中国石油大学(北京)新生PPD试验结果与结核发病情况分析》一文的商榷意见的答复[J]. 中国防痨杂志, 2015, 37(9): 1001-1002. |
[8] | 孟炜丽,罗萍,胡京坤,孙钊,李慧颖,连赫宇. BCG-PPD与TB-PPD皮肤试验在大学生结核病筛查中的差异性分析[J]. 中国防痨杂志, 2014, 36(7): 542-546. |
[9] | 江渊,王曲直,张阳奕,沈素芳,李静,唐文红,桂晓虹,梅建,潘启超,沈鑫. 快速检测技术在奶牛结核病检测中的应用研究[J]. 中国防痨杂志, 2014, 36(6): 447-452. |
[10] | 葛燕萍,肖和平. γ干扰素释放试验与结核菌素皮肤试验辅助检测肺外结核病的比较[J]. 中国防痨杂志, 2014, 36(3): 194-197. |
[11] | 耿梦杰,宋渝丹,熊勇超,赵飞,胡冬梅,李萌,侯月云,成君,何广学. 结核菌素皮肤试验和γ干扰素释放试验检测917名医务人员结核分枝杆菌感染一致性的比较分析[J]. 中国防痨杂志, 2014, 36(2): 121-125. |
[12] | 路希维. 学校结核病暴发控制策略研究进展[J]. 中国防痨杂志, 2013, 35(9): 752-756. |
[13] | 陈曦 王丽. 2009—2012年中央财经大学入学新生PPD试验结果分析[J]. 中国防痨杂志, 2013, 35(11): 887-890. |
[14] | 曾谊 冯枭 宋梅梅 林云霞 费贤树 袁广琴. 酶联免疫斑点试验在菌阴肺结核诊断中的价值[J]. 中国防痨杂志, 2012, 34(2): 100-102. |
[15] | 陈淑林 孙德全 石俊峰 张爱红 夏建华. 高中生PPD反应程度与结核病发病危险的队列研究[J]. 中国防痨杂志, 2012, 34(12): 799-802. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||